Rare diseases
Investigational molecules
Locations
Study of mRNA-4157 and Pembrolizumab for Patients with High-Risk Stage II-IV Melanoma
FranceStudy of Upadacitinib and Topical Corticosteroids for Adolescents and Adults with Moderate to Severe Eczema
FranceStudy on the Effectiveness and Safety of Afimetoran for Patients with Active Lupus
FranceStudy on the Effects of Samuraciclib and Elacestrant for Patients with Hormone Receptor-Positive, HER2-Negative Breast Cancer
FranceStudy Comparing Odronextamab and Lenalidomide with Rituximab and Lenalidomide for Patients with Relapsed/Refractory Follicular and Marginal Zone Lymphoma
FranceStudy on the Effects of MBS2320 for Patients with Idiopathic Pulmonary Fibrosis (IPF)
FranceStudy Comparing Pembrolizumab and Placebo for Patients with Resected High-Risk Stage II Melanoma
FranceStudy on the Safety and Effectiveness of BLU-222 Alone and with Drug Combination for Patients with Advanced Solid Tumors, Including Breast and Ovarian Cancer
FranceStudy of Atezolizumab, Bevacizumab, and Tiragolumab for Patients with Untreated Advanced or Metastatic Liver Cancer
FranceStudy of BMS-986449 and Nivolumab for Patients with Advanced Solid Tumors
FranceStudy on the Effectiveness and Safety of Apalutamide and GnRH Agonist in Patients with High-Risk Prostate Cancer Undergoing Radiation Therapy
FranceStudy on Long-Term Safety and Efficacy of Ianalumab for Patients with Sjögren’s Syndrome
FranceTell us about your condition – we search every trial in Europe and connect you with the right site.
